Jessica M. Peng

Jessica M. Peng, PharmD, serves as a Senior Regulatory Strategy Manager at Neurocrine Biosciences, where responsibilities include supporting early phase CTA and pre-IND activities, and devising regulatory strategies for various submission types. Previously, at Ascendis Pharma A/S, Jessica Peng was a Regulatory Affairs Manager, successfully submitting the original BLA filing and managing an active US IND and BLA in the drug-device combination context. Earlier roles included Clinical Scientist positions at Ascendis and Insys Therapeutics, where contributions involved advisory committee meeting preparations and clinical development support. Jessica M. Peng’s career also includes a clerkship at Eli Lilly and research experience at Northwestern Memorial Hospital, complemented by a Doctor of Pharmacy degree from Midwestern University.